Next Article in Journal
A New Modified Firefly Algorithm for Optimizing a Supply Chain Network Problem
Previous Article in Journal
Analysis of Lookout Activity in a Simulated Environment to Investigate Maritime Accidents Caused by Human Error
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Process Design of the Antioxidant Shuidouchi and Its Effect on Preventing Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice via Antioxidant Activity

1
Environment and Quality Inspection College, Chongqing Chemical Industry Vocational College, Chongqing 401228, China
2
Chongqing Collaborative Innovation Center for Functional Food, Chongqing University of Education, Chongqing 400067, China
3
College of Life Sciences, Chongqing Normal University, Chongqing 400047, China
4
Department of Food Science and Biotechnology, Cha University, Seongnam 13488, Gyeongghi-do, Korea
5
College of Food Science, Southwest University, Chongqing 400715, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Appl. Sci. 2019, 9(1), 5; https://doi.org/10.3390/app9010005
Submission received: 28 November 2018 / Revised: 9 December 2018 / Accepted: 17 December 2018 / Published: 20 December 2018
(This article belongs to the Section Chemical and Molecular Sciences)

Abstract

:
Shuidouchi is a traditionally fermented soybean product in China. Shuidouchi production requires a variety of processes; however, the production process has not been standardized. It can be developed into high-quality products with enhanced health effects by improving the design of its fermentation process and increasing the content of its active ingredients. In this study, a single-factor experiment was conducted that established different process conditions to determine the fermentation conditions that achieve the highest content of active ingredients and the best in vitro antioxidant effect. The effect of Shuidouchi on the prevention of dextran sulfate sodium-induced colitis in mice was also observed. The obtained results indicated that the optimal process conditions involved soaking for 12 h, placement in a glass container, and fermentation at 35 °C for 48 h. Shuidouchi that was fermented under such conditions had the highest level of soybean isoflavones and exerted greater antioxidant effects than if fermented under other conditions. The Shuidouchi extract (soaking twice the quantity of water for 12 h, placing in a glass container, and fermenting at 35 °C for 48 h) obtained by using the optimal fermentation process can prevent the shortening of the colon and increase the weight-to-length ratio of the colon that is caused by colitis. Shuidouchi extraction not only effectively reduces the disease activity index and the levels of serum endothelin (ET), substance P (SP), and interleukin-10 (IL-10), it also increases the levels of somatostatin (SS), vasoactive intestinal peptide (VIP), and interleukin-2 (IL-2) of mice with colitis. In addition, Shuidouchi extraction increased the levels of glutathione (GSH) and superoxide dismutase (SOD) in colitis mice; in contrast, Shuidouchi decreased the levels of myeloperoxidase (MPO) and malondialdehyde (MDA) in the colon of mice with colitis. Further detection of mRNA in colon tissues showed that Shuidouchi extraction can upregulate the expression of neuronal nitric oxide synthase (nNOS), endothelial nitric oxide synthase (eNOS), c-Kit, and the stem cell factor (SCF). Furthermore, it can downregulate the expression of inducible nitric oxide synthase (iNOS), interleukin-8 (IL-8), and C-X-C chemokine receptor type 2 (CXCR2) in the colon of mice with colitis. Further experimental results showed that Shuidouchi could reduce the protein expression of interleukin 6 (IL-6), IL-12, and tumor necrosis factor-α (TNF-α) in colitic mice. Therefore, the improved processing of Shuidouchi inhibits colitis, which is directly related to the high content of soybean isoflavones.

1. Introduction

Douchi is a traditional fermented soybean product in China with both desirable taste and functional effects [1]. Shuidouchi is a type of bacterial Douchi, which is a type of seasoning that is fermented by bacterial action, which has a history of use as seasoning or as a dish for thousands of years. It was used not only as a simple food but also as a type of medicine in ancient Chinese medical books. Shuidouchi was also used as a traditional Chinese medicine with appetite-stimulating effects that strengthens the spleen, eliminates heat, and exerts detoxifying effects [2]. Modern scientific research methods have identified many functional ingredients in Shuidouchi, which confer antioxidant, antimutagenic, and anticancer effects of soybean products (e.g., Douchi, Shuidouchi, and soy sauce) [3]. However, studies on the physiological activity of Shuidouchi have rarely been conducted.
Chinese Shuidouchi, Japanese Natto, and Korean Koji sauce are typical examples of food from bacterially fermented soybeans. Japan was the first to isolate and identify the fermentation strain of Natto and simultaneously develop purely fermented Natto products after an in-depth study of the physiological activities of Natto. The study reported that Natto exhibits antioxidant, anti-inflammatory, and anticancer effects [4,5,6]. These three bacterially fermented soybean foods (Chinese Shuidouchi, Japanese Natto, and Korean Chungkukjang) are all produced with similar technology. Japanese Natto and Korean Chungkukjang have been fully studied and reported to date, including process improvement, functional effects, and extraction of active ingredients [7,8]. In China, only a few preliminary studies have been conducted on Shuidouchi, indicating its anti-inflammatory and anti-cancer effects [7]. The specific mechanism and process improvement of Shuidouchi have not been explored sufficiently.
Previous studies showed that the quality of soybean sauce was related to numerous factors, such as the fermentation bacteria, the amount of water for soaking the soybeans, the fermentation time, fermentation temperature, and the time after fermentation [9,10]. In addition, the fermentation container is also one of the factors to affect the quality of fermented soybean products [11]. A study confirmed that the quality of Korean Chungkukjang was related to these fermentation factors [7]. In China, the effects of single factors, such as fermentation temperature, fermentation time, and fermentation container on the quality of Shuidouchi were partially confirmed [2,9,12]. The optimal combination of these factors and the optimal fermentation process is the focus of this study.
Intestinal health plays an important role for maintaining high quality of life. Digestive absorption, metabolism, and mucosal immunity can decline with age, and the number of probiotics in the digestive system can rapidly decrease. Intestinal canal aging can simultaneously lead to difficulty in defecation, flatulence, dyspepsia, and accumulation of vivotoxins, which, among other issues, influence human health [13]. Almost 95% of the Chinese suffer from intestinal diseases, which severely influences their health and quality of life. Constipation, colitis, and colon cancer are critical intestinal diseases posing considerable risks for human health [14].
Shuidouchi is rich in thrombolytic ingredients, soybean polypeptides, soybean oligosaccharides, protein melanin, soybean saponins, complex digestive enzymes, active isoflavones, vitamin B1, microbial B2, vitamin C, vitamin E, amino acids, and further bioactive substances [15,16]. The active ingredients of soybean polypeptides, soybean oligosaccharides, protein melanin, soybean saponins, complex digestive enzymes, active isoflavones in Shuidouchi have been suggested to alleviate constipation and prevent both colitis and colon cancer [2,3]. More active substances could be produced by improving the fermentation process of Shuidouchi. These active ingredients would be more conducive to the protection of the intestinal tract and the prevention of colitis. The purpose of this study is to explore the mechanism underlying Shuidouchi efficacy using molecular biology technologies, improve the preventive effect of Shuidouchi on colitis, and to accumulate a solid theoretical basis for the further development of functional Shuidouchi.

2. Materials and Methods

2.1. Fermentation of Shuidouchi

Shuidouchi was fermented at different temperatures: 100 g of soybeans (Zhongnong Xianheng Agricultural Development Co., Ltd., Beijing, China) were weighed in 200 mL distilled water for 12 h and the soaked soybeans were boiled in a high-pressure sterilizing pot for 1 h. The boiled soybeans were cooled to 30 °C, 35 °C, and 40 °C, and then fermented in a glass container for 48 h (Figure 1A).
Shuidouchi was fermented for different durations: 100 g of soybeans were weighed in 200 mL distilled water for 12 h and the soaked soybeans were boiled in a high-pressure sterilizing pot for 1 h. The boiled soybeans were cooled to 35 °C and then fermented in a glass container for 24, 48, and 72 h (Figure 1B).
Shuidouchi was fermented using different amounts of soybeans: 100 g of soybeans were weighed in 100, 200, and 300 mL distilled water for 12 h. The soaked soybeans were boiled in a high-pressure sterilizing pot for 1 h. The boiled soybeans were cooled to 35 °C and then fermented in a glass container for 48 h (Figure 1C).
Shuidouchi was fermented in different containers: 100 g of soybeans were weighed in 200 mL distilled water for 12 h. The soaked soybeans were boiled in a high-pressure sterilizing pot for 1 h. The boiled soybeans were cooled to 35 °C and then fermented in ceramic, glass, or metal containers for 48 h (Figure 1D).

2.2. Shuidouchi Extraction

Shuidouchi was frozen-dried and crushed, and then the Shuidouchi powder was extracted by a 20-fold diluted (w/v) ethanol for 12 h. The extract was filtered, the filtrate was retained, and the filtrate residue was extracted again by the above method [2].

2.3. Determination of Free Radical Scavening Rate of Shuidouchi by DPPH

Reagents (Shanghai Jinsui Biotechnology Co., Ltd., Shanghai, China) (Table 1) were added into the extracted Shuidouchi, and for a final reaction, 200 µl of DPPH (2,2-Diphenyl-1-picrylhydrazyl) solution (Shanghai Jinsui Biotechnology Co., Ltd., Shanghai, China) (60 µM) was added to wells of 96-well plate containing 50 µl of Shuidouchi extract, which was stored in the dark for 90 min. The absorbance was measured at 517 nm and the radical scavenging rate was calculated [15]. DPPH (%) was expressed as A3-(A1-A2)/A3 × 100. The calculation of IC50 when the DPPH radical was scavenged up to 50% was conducted according to the T logarithm (X) of the concentration of the DPPH radical plotted by the clearance rate (Y); a linear equation was thus obtained. The IC50 was derived from the linear equation.

2.4. Determination of Free Radical Scavenging Rate of Shuidouchi by ABTS+

Reagents (Table 2) were added to the Shuidouchi extract, and a final reaction solution (200 µL) was added to a 96-well plate after storage in the dark for 6 min. Absorbance was measured at 734 nm. The radical scavenging rate was also calculated. The computational formula for the 2,2’-azino-bis(3-ethylbenzthiazoline) 6-sulphonic acid (ABTS+) radical scavenging rate is ABTS+(%) = A3-(A1-A2)/A3 × 100. The calculation of the required extract concentration, which is an ABTS+ free radical, reached up to 50%. The elimination rate (Y) was plotted with the logarithm (X) of the concentration of the extract and its linear equation was obtained. The IC50 was determined in accordance with the linear equation.

2.5. Determination of the Free Radical Scavenging Rate Of Shuidouchi by the Hydroxyl Radical Method

Reagents (Table 3) were added to the Shuidouchi extract sample and heated for 30 min in a water bat at 37 °C. The final reaction solution (200 µL) was added to the 96-well plate. Absorbance was measured at 510 nm and the free radical scavenging rate was calculated. The computational formula for the hydroxyl radical scavenging rate is OH (%) = A3-(A1-A2)/A3 × 100. The required extraction concentration (IC50) when hydroxyl radicals were cleared to 50% was calculated by plotting the elimination rate (Y) with the logarithm (X) of the extract concentration, and the linear equation was obtained. The IC50 was obtained based on this linear equation.

2.6. Determination of Soybean Isoflavones in Shuidouchi

10.2 mg of genistein standard solution (Shanghai Yuanye Biotechnology Co., Ltd., Shanghai, China) was precisely weighed and poured into a 50 mL volumetric flask. 0.01 mol/L NaOH (Sinopharm Chemical Reagent Co., Ltd., Shanghai, China) solution was then added to achieve a volume of 50 mL. After the configuration of the base solution, 1.0, 2.0, 3.0, 4.0, and 5.0 mL solutions were precisely extracted and placed in a 100 mL volumetric flask. Subsequently, 0.01 mol/L NaOH solution was added to a 100 mL scale. The absorbance values of all solutions at 271 nm were measured with a 0.01 mol/L NaOH blank solution. A standard curve was generated, with the absorbance values (Y) on the ordinate and the concentrations of genistein (µL/mL) on the abscissa. After the standard curve was determined, the Shuidouchi sample was dissolved in a 0.01 mol/L NaOH solution and the absorbance value was determined at 271 nm. The standard curve of the soybean isoflavones content was ultimately obtained (genistein meter, Figure 2).

2.7. Animal Experiment

A total of 50 Kunming mice (seven weeks old, 25 male and 25 female) were kept at 25 ± 2 °C, 50 ± 5% in a feeding environment with relative humidity and with light and shade indoors adjusted alternately every 12 h. A second set of 50 mice with similar body weights were randomly divided into five groups: normal group, control group, SDC-L group (mice were fed with low-concentration (2 g/kg) Shuidouchi extract by gavage), SDC-H group (mice were fed via gavage with high-concentration (4 g/kg) Shuidouchi extract), and sulfasalazine group (positive control group). After the onset of the experiment, mice in each group were freely fed with the respective diet. Except for mice in the normal group, all other mice received 2% (w/v) DSS solution as drinking water during the third week. After feeding distilled water for one week, all other mice except for the normal group received 4% (w/v) DSS solution as drinking water during the fifth week. Except for the third and fifth weeks, all mice received distilled water as drinking water for the rest of the time [16,17]. During the entire experimental duration of five weeks, the SDC-L and SDC-H groups received 2 and 4 g/kg of extract of Shuidouchi daily after the optimization of crafts. The mice in the sulfasalazine group were fed with 20 mg/kg sulfasalazine daily. All mice fasted for 24 h on Day 35 and were killed on Day 36. The colon length and weight of each mouse were measured and the colon weight/colon length index was then calculated. The disease activity index (DAI) of each mouse was simultaneously calculated, as follows: DAI = (fraction of weight loss + fraction of stool shape + fraction of stool occult blood)/3 (Table 4). The blood and colon tissues were also collected for later use. The protocol for these experiments was approved by the Animal Ethics Committee of the Chongqing Medical University under the animal permit number SYXK (Yu) 2018-0003.

2.8. Determination of Endothelin (Et), Somatostatin (Ss), Substance P (Sp), and Vasoactive Intestinal Peptide (Vip) and Levels of Serum in Mice

Serum was obtained from mice by centrifugation (4500 r/min, 15 min). The endothelin (ET-1), somatostatin (SS), substance P (SP), and vasoactive intestinal peptide (VIP) levels in serum were determined using the respective kits (Abcam, Cambridge, MA, USA) [18].

2.9. Determination of Interleukin (IL)-2 and Interleukin-10 (IL-10) Cytokines of Serum in Mice

Serum was obtained by centrifugation of the mouse plasma using the 2.8 method. The interleukin (IL)-2 and IL-10 cytokine levels in serum were then determined using the respective kits (Abcam, Cambridge, MA, USA) [18].

2.10. Determination of Malondialdehyde, Myeloperoxidase, Superoxide Dismutase, and Glutathione Levels in the Colon Tissue of Mice

The colon tissue of mice and normal saline were mixed at a mass ratio of 1:9. The colon tissue was then homogenized by ultrasonic pulverization, and the levels of myeloperoxidase (MPO), superoxide dismutase (SOD), glutathione (GSH), and malondialdehyde (MDA) in the colon tissue were determined while using the respective kits (Nanjing Jiancheng Bioengineering Institute, Nanjing City, China) [18].

2.11. Detection of mRNA Expression in Colon Tissue of Mice by qPCR

The colon tissue of mice was homogenized, and RNA TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) was used to extract the total RNA, which was then diluted to 1 μg/μL. The diluted RNA solution of 5 μL was obtained using a reverse transcription kit and the cDNA template was obtained. Subsequently, 2 μL of the cDNA template was mixed with 10 μL SYBR Green PCR (polymerase chain reaction) Master Mix and 1 μL upstream and downstream primers (Thermo Fisher Scientific, Waltham, MA, USA) (Table 5). A total of 40 cycles were conducted after which the reaction conditions were as follows: 95 °C, 60 s; 95 °C, 15 s; 55 °C, 30 s; and, 7 °C, 35 s (StepOnePlus Real-Time PCR System, Thermo Fisher Scientific, Waltham, MA, USA). Relative gene expression was calculated using the 2-ΔΔCt method, using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as internal reference [17].

2.12. Western Blot Analysis

100 mg colon tissue was homogenized with 1 mL RIPA and 10 µL PMSF (phenylmethylsulfonyl fluoride) (Thermo Fisher Scientific); then, the mixture was centrifuged at 12000 r/min for 5 min. The intermediate protein layer solution was removed. A BCA protein quantitative kit (Thermo Fisher Scientific) was used to quantify proteins. The samples of each group were diluted to 50 g/mL and then the diluted proteins were mixed with sample buffer at 4:1 and heated for 5 min at 100 °C. Acrylamide, resolving buffer, starcking buffer, ditilled water, 10% APS (ammonium persulfate), and TEMED (tetramethylethylenediamine, Thermo Fisher Scientific) were mixed proportionally to form an SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electropheresis) (Thermo Fisher Scientific) separating and concentrating glue, which was poured into the runner board for later useage. The prestained protein ladder and samples were put into the sample holes of the rubber sheet, and then the loaded SDS-PAGE gel was subjected to 50 min vertical gel electrophoresis. The PVDF (polyvinylidene fluoride) membrane was activated by methanol for 1 min and then the transmembrane was closed by TBST (tris buffered saline tween) solution containing 5% skim milk for 1 h. After closure, the PVDF membrane was washed by TBST, the primary antibodies (IL-6, IL-12, and TNF-α, Thermo Fisher Scientific) were incubated at 25 °C for 2 h, and the secondary antibody was incubated at 25 °C for 1 h. Finally, Supersignal West Pico PLUS was used to spray the PVDF film, followed by placin into iBright FL1000 (Thermo Fisher Scientific) for observation [17].

2.13. Statistical Analysis

The averages of the results of three parallel experiments were calculated. The SAS9.1 statistical software (SAS Institute Inc., Cary, NC, USA) was used for data analysis, and one-way ANOVA according to Duncan’s multiple-range test was conducted to determine statistical significance.

3. Results

3.1. Comparison of Soybean Isoflavone Contents of Shuidouchi Fermented at Different Temperatures

The soybean isoflavone contents in Shuidouchi extract fermented at 30 °C, 35 °C, and 40 °C were 42.52, 58.87, and 46.33 mg/g, respectively, which was in accordance with the standard curve Y = 0.1709X + 0.0095 (Figure 2). With the same determination method, the unfermented soybean showed a soybean isoflavone content of 33.71 mg/g (Figure 3).

3.2. Comparison of Antioxidant Effects of Shuidouchi after Fermentation at Different Temperatures

The results of Figure 4 and Table 6 indicate that, under the same fermentation conditions (specifically, the same concentration), the DPPH, ABTS+, and hydroxyl radical scavenging capacities of Shuidouchi extract fermented at 35 °C exceed those fermented at 30 °C and 40 °C. Further calculation confirmed that the IC50 of Shuidouchi extract fermented at 35 °C was significantly lower than those of Shuidouchi extracts fermented at both 30 °C and 40 °C. Despite the decreased concentrations, Shuidouchi that was fermented at 35 °C could exert the same effect and achieved better antioxidant effects as those fermented at 30 °C and 40 °C, respectively.

3.3. Comparison of Soybean Isoflavone Contents of Shuidouchi Fermented for Different Durations

The soybean isoflavone contents of Shuidouchi fermented for 24, 48, and 72 h were 35.67, 58.87, and 48.51 mg/g, respectively (Figure 5). The soybean isoflavone content of unfermented soybean was 33.71 mg/g.

3.4. Comparison of Antioxidant Effects of Shuidouchi Fermented for Different Durations

The results in Figure 6 and Table 7 indicate that fermentation duration influences the antioxidant effects of Shuidouchi under otherwise identical conditions. The DPPH, ABTS+, and hydroxyl radical scavenging rates of Shuidouchi fermented for 24, 48, and 72 h were significantly different. The DPPH, ABTS+, and hydroxyl radicals scavenging rates of Shuidouchi extract that was fermented for 48 h were higher than those of Shuidouchi extract fermented for 24 and 72 h.

3.5. Comparison of Soybean Isoflavone Contents of Shuidouchi Soaked in Different Water Quantities

The soybean isoflavone contents in fermented Shuidouchi extract that was soaked in different quantities of water were 40.35, 58.87, and 56.37 mg/g (genistein meter), respectively. Unfermented soybeans contained 33.71 mg/g soybean isoflavone, which was in accordance with the standard curve for genistein, Y = 0.1709X + 0.0095 (Figure 7).

3.6. Comparison of Antioxidant Effects of Shuidouchi in Different Quantities of Soaking Water

The results that are shown in Figure 8 and Table 8 indicate that the quantity of soaking water affects the antioxidant effects of Shuidouchi extract. The extracts soaked in two and three times more water exerted enhanced antioxidant effects, with the former exhibiting slightly better antioxidant effects than the latter.

3.7. Comparison of Soybean Isoflavone Contents on Shuidouchi Fermented in Different Containers

In accordance with the standard curve Y = 0.1709X + 0.0095 for genistein, the soybean isoflavone content of unfermented soybean was 33.71 mg/g; furthermore, the soybean isoflavone contents in the Shuidouchi extract fermented in ceramic, glass, and metal containers were 47.74, 58.87, and 44.12 mg/g, respectively (Figure 9).

3.8. Comparison of Antioxidant Effects of Shuidouchi Fermented in Different Containers

The results that are shown in Figure 10 and Table 9 show that, under otherwise identical fermentation conditions, the fermentation container affects Shuidouchi fermentation. The antioxidant effect of Shuidouchi fermented in the glass container exceeded that of Shuidouchi that was fermented in ceramic and metal containers.
Due to the different materials of fermentation containers, the temperature and water content of fermentation products can differ, thus resulting in different growth of fermentation microorganisms, which in turn affects the fermentation products [19]. After analyzing various fermentation factors, it was found that Shuidouchi fermented under specific condition (twice as much soaking water in glass container at 35 °C for 48 h) contained the most soybean isoflavones. This particular fermented Shuidouchi showed the highest DPPH, ABTS+, and hydroxyl radical scavenging capacities of all the different tested conditions. These results indicate that soybean isoflavone is an important active component that is produced by the antioxidant effect of Shuidouchi and exhibits a direct relationship with the antioxidant effect.

3.9. Effects of Shuidouchi on Colonic Length and Weight of Mice with Colitis

The results showed that the normal group had the longest colon but the least colon weight-to-colon length ratio (Table 10). The results that were obtained for the control group were opposite to those obtained for the normal group. The control group showed the shortest colon length and the largest colon weight-to-colon length ratio. The colon length and the colon weight-to-colon length ratio of the SDC-H group were closest to those of the normal group. The colon of the SDC-H group was only slightly shorter than those of both the normal group and the sulfasalazine group and longer than those of the control group and the SDC-L group. Furthermore, the colon weight-to-colon length ratio of the SDC-H group was higher than those of the normal group and the sulfasalazine group and lower than those of the control group and the SDC-L group.

3.10. Effects of Shuidouchi on Disease Activity Index of Mice with Colitis

The results showed that the DAI index of the control group was higher than that of the other groups during the experimental period and that the DAI indices of the mice in all groups, except for the normal group, increased significantly after treatment with DSS at Weeks 3 (2.32) and 5 (3.62) (Figure 11). On the 35th day, the SDC-L (2.68), SDC-H (1.89), and sulfasalazine (1.52) groups showed significant inhibitions of the increase in the DAI index in mice with colitis, with sulfasalazine exhibiting the highest inhibition, followed by SDC-H, and then SDC-L. Therefore, the improved Shuidouchi extract fermentation process could inhibit the increase of DAI index in mice with colitis.

3.11. Effects of Shuidouchi on Serum Levels of Et, Ss, Sp, And Vip in Mice with Colitis

The results in Table 11 show that the ET and SP serum levels of the normal group are the lowest, while the SS and VIP serum levels are the highest; the ET and SP serum levels of the control group are the highest, while the SS and VIP levels are the lowest. The SDC-L, SDC-H, and sulfasalazine groups could significantly decrease the ET and SP levels and increase the SS and VIP levels in mice with colitis. Sulfasalazine exerted the strongest effect, followed by high concentration of Shuidouchi, and then low concentration of Shuidouchi.

3.12. Effects of Shuidouchi on Serum Levels of Il-2 and Il-10 Cytokines in Mice With Colitis

The results in Table 12 show that the IL-2 levels are lowest in all groups, and the IL-10 in the control group is the highest; the sulfasalazine, SDC-H, and SDC-L groups show significant increases of IL-2 levels and decreased IL-10 levels. Due to sulfasalazine, SDC-H, and SDC-L, the IL-2 and IL-10 cytokine levels in the sulfasalazine group were the closest to those in the normal group. The IL-2 and IL-10 levels in the SDC-H group were similar to those in the normal group, which significantly improved the IL-2 and IL-10 serum cytokine levels in mice with colon cancer.

3.13. Effects of Shuidouchi on the Myeloperoxidase, Superoxide Dismutase, Glutathione, and Malondialdehyde Levels in the Colon Tissue of Mice With Colitis

The results in Table 13 show that the normal group exhibits the highest GSH and SOD levels, but the lowest MPO and MDA levels. After colitis induction, the GSH and SOD levels decreased, while the MPO and MDA levels increased in DSS-induced mice. Significant inhibition of decreases in GSH and SOD and increases in MPO and MDA levels caused by colitis were found in the sulfasalazine, SDC-H, and SDC-L groups. Sulfasalazine showed the strongest inhibitory action, followed by SDC-H and SDC-L.

3.14. Effects of Shuidouchi on Expression of Nnos, Enos, and Inos Mrna in Colon Tissues of Mice with Colitis

The results showed that the expression of nNOS mRNA in the colon tissue of the normal group was 4.36 times that of mice in the control group, and the expression levels of nNOS in the colon tissues in the SDC-H, SDC-L, and SDC-H groups were 3.23, 2.79, and 1.87 times that of the control group, respectively (Figure 12). The colon tissues in the normal group exhibited the highest eNOS expression (3.79 times of that in the control group); eNOS expression in the sulfasalazine group was only 3.01 times that in the normal group (3.01 times that in the control group); and, eNOS expression in the SDC-H group (2.62 times that in the control group) was higher than that in the SDC-L group. (1.92 times in the control group). In contrast, the colon tissues of the normal group showed the lowest iNOS mRNA expression, which was only 0.25 times that of the control group. After treatment with sulfasalazine, high Shuidoichi concentration, and low Shuidoichi concentration, the expressions of iNOS mRNA in the colon of mice with colitis decreased to 0.41, 0.52, and 0.79, respectively, of that of the control group.

3.15. Effects of Shuidouchi on Expression of c-Kit and SCF mRNA in Colon Tissues of Mice with Colitis

The results in Figure 13 show that the expression of c-Kit mRNA in the colon of the normal group (6.38 times of that of the control mice) was significantly higher than that in the other groups. The expression of c-Kit mRNA in the colon of the sulfasalazine group (5.52 times of that of the control mice) and SDC-H group mice (4.8 times of that of the control mice) was also higher than that of the SDC-L group (2.71 times of that of the control group). Simultaneously, the expression levels of SCF mRNA in the colon tissues of the normal group, sulfasalazine group, SDC-H group, and SDC-L group were 5.33, 4.89, 4.36, and 2.21 of that of the control group, respectively.

3.16. Effects of Shuidouchi on Expression Levels of IL-8 and CXCR2 Mrna in Colon Tissues of Mice with Colitis

The IL-8 mRNA expression in the colonic tissue of mice of the normal group was 0.14 times that of the control group, which was weaker than that of the sulfasalazine group (0.22 times of that of the control group), SDC-H group (0.38 times of that of the control group), and SDC-L group (0.69 times of that of the control group; Figure 14). The control group exhibited the highest CXCR2 mRNA expression. The CXCR2 expression levels in the normal group, sulfasalazine group, SDC-H group, and SDC-L group were 0.19, 0.35, 0.44, and 0.65 times higher than that of the control group.

3.17. Effects of Shuidouchi on Expression Levels of IL-6, IL-12, and TNF-A Protein in Colonic Tissues of Mice with Colitis

The IL-6, IL-12, and TNF-α protein expression levels in the colonic tissue of mice of the normal group were weakest, but their expressions in mice of the control group were the strongest (Figure 15). Following Shuidouchi treatment, the IL-6, IL-12, and TNF-α protein expression were decreased when compared to the control group, and the SDC-H showed a better reducing effect than SDC-L; the effects of SDC-H were close to that of sulfasalazine.

4. Discussion

The DPPH method is generally used to evaluate the antioxidant effects and the antioxidant capacity of active substances. The DPPH radical with a single electron is a stable free radical. In the presence of a free radical scavenger, the free radical pairs with its single electron to reduce its absorption, and this change can evaluate the antioxidant properties of active substances [20]. ABTS+ free radicals become green during oxidization. When antioxidants exist, ABTS+ reacts with antioxidants and decreases the color of ABTS+ free radicals. The antioxidant effect can be evaluated by the degree of fading [21]. The hydroxyl free radical is a highly active and highly toxic oxygen-free radical, which is the main factor that leads to disease and aging and it can considerably harm the body [22]. In the present study, three methods were used to evaluate the antioxidant effects of Shuidouchi that was fermented with different techniques; the highest antioxidant activity of Shuidouchi was preliminarily obtained. Studies have shown that soybean isoflavones can significantly reduce lipid peroxidation and improve the levels of the blood total antioxidant status (TAS). It can effectively scavenge free radicals, stop the chain reaction of free radicals, and prevent the oxidation of unsaturated fatty acids in lipids and endothelial membranes, thus preventing many diseases that are caused by free radicals in vivo [23]. In the current study, the soybean isoflavone content in Shuidouchi was determined, and the Shuidouchi with the best antioxidant efficacy was designed. Studies have indicated that antioxygen is gradually applied in the clinical setting. Colitis can be inhibited because antioxygen scavenging free radicals inhibit peroxidation and inflammation [24]. Soybean isoflavone is the main source of the antioxidant capacity of soybeans, which exerts a good anti-inflammatory and anti-cancer role [25]. Thus, the current study also tests the intestinal protection of Shuidouchi by designing its best antioxidant effect. To some extent, DPPH scavenging free radicals indicated the antioxidant capacity of Shuidouchi; however, the effect and utilization rate of DPPH in organisms requires further study.
Colitis is a type of intestinal inflammation, which includes ulcerative colitis, ischemic colitis, and pseudomembranous colitis. Ulcerative colitis exhibits the highest incidence, reaching 10/100,000 [26]. Studies have shown that patients with ulcerative colitis, who have a medical history of 10 y, have a greatly increased risk of colon cancer, posing a risk of almost 10% for patients with a medical history of 25 y [27]. Food therapy for the prevention of severe intestinal diseases is currently a widely studied subject. In the present study, the animal model with colitis was treated with Shuidouchi that was fermented using an improved method and the preventive effects of such a method on colitis was observed. Colitis can cause the erosion and swelling of colonic mucosa, which can shorten the intestinal canal; as a result of the swollen and congested colon, the weight of the colon increases and the colon shortens, which leads to an increase in the ratio of the weight of the colon to the length of the colon. Previous studies indicated that this colon mass-to-colon length ratio is an important indicator of the degree of experimental ulcerative colitis. The higher the severity of colitis, the shorter the colon length in mice and the larger the colon mass-to-colon length ratio [28]. In the current study, mice with DSS-induced colitis showed a shorter colon and a larger colon weight-to-colon length ratio. Shuidouchi extract could significantly inhibit these changes and thus prevent colitis. The DAI index is an important index for the observation of colitis in mice. With aggravated inflammation, the DAI increases, and the DAI index decreases after the remission of colitis [28]. Consequently, colitis in mice could be relieved using Shuidouchi extract from Shuidouchi that was fermented with the improved process.
Studies have shown that the contractile effect of endothelin on blood vessels can lead to colonic mucosal erosion, which can result in ulcers in severe cases that aggravate colitis [29]. SS inhibits gastric acid secretion and suppresses gastrointestinal inflammation. Deficiency in SS can promote a large amount of gastrointestinal fluid secretion and aggravate colitis [30]. SP regulates the nervous and immune systems of the body, and the accumulation of substance P in the body leads to an aggravation of colitis [31]. Excessive SP can directly result in colitis and it can inhibit colitis in antagonistic antibodies [32]. VIP can regulate the iNOS transcription in vivo, inhibiting the conversion of excessive iNOS to NO in colonic tissues and avoid intestinal mucosal damage that is caused by large amounts of NO. VIP can also inhibit disorders of the immune system that are caused by colitis [33]. Therefore, Shuidouchi fermented using this improved technique can protect the colon and prevent colitis by regulating the ET, SS, SP, and VIP.
IL-2 is a cytokine secreted by Th2 cells, which are directly related to colitis. Th2 cells can mediate the immune response to exert an effect on colitis. IL-2 can inhibit colitis by influencing Th2 cells [34]. IL-10 is a cytokine that is secreted by Treg cells, which exert an immunosuppressive effect to aggravate colitis [35]. The obtained results indicate that Shuidouchi that was fermented with this improved process can inhibit colitis by regulating the cytokines IL-2 and IL-10.
After the onset of colitis, the original aggregated neutrophils in the colon disperse, and the influx of neutrophils into the tissues markedly increases the MPO level [36]. After inflammation, free radicals, such as ROS and RNS, accumulate rapidly in vivo; consequently, the damage and toxicity of the colon tissue are further aggravated, and the degree of colitis is considerably increased [37]. Studies have shown that the GSH and SOD levels in colonic tissues decreased in response to colitis, whereas MDA, a peroxide product, increased significantly [38]. In the current study, the improved Shuidouchi process significantly influenced the MPO, SOD, GSH, and MDA levels in mice with colitis and can thus prevent colitis. The antioxidant capacity of Shuidouchi is directly reflected in the impact on the above indexes in vivo; therefore, the effects of Shuidouchi on colitis are directly related to its antioxidant effect.
The results showed that nNOS could regulate the concentration of NO in tissues and protect tissues from damage that is caused by excessive NO. Simultaneously, nNOS can control iNOS and avoid iNOS overexpression, thus resulting in an aggravation of inflammation [39]. eNOS can regulate the NO level in the body, thus maintaining the balance of NO in the body and the normal state of the colon tissues, which can regulate colon tissue injury and colitis [40]. NO is produced by two cNOS subtypes that are associated with iNOS, accelerating nitrification and oxidative damage, while also increasing inflammatory factors [41]. A high amount of iNOS can convert an equally high amount of NO, and excessive NO can lead to colonic tissue damage, resulting in the aggravation of colitis [40]. Studies have also shown that the expression pattern of iNOS is related to inflammation, and the inhibition of iNOS can reduce inflammation [41]. Simultaneously, inflammatory bowel disease (IBD) is associated with the excessive production of NO by iNOS, and the amount of NO in the intestinal tract and saliva of patients with IBD is increased when compared to control subjects [42]. Animal experiments have also shown that the inhibition of iNOS attenuated the DSS-induced colitis in mice [43]. The results of the present study also indicate that this improved Shuidouchi fermentation could prevent colitis by regulating the expression levels of nNOS, eNOS, and iNOS in the colon.
Colitis occurs in response to colon dysfunction and a decline in colon motility; furthermore, colitis can also cause a decrease in the number of normal interstitial Cajal cells, thus reducing colon motility, which is directly related to colitis [44]. C-Kit can maintain the number of interstitial Cajal cells and prevent the aggravation of colitis [45]. SCF also plays an important role in maintaining the number of interstitial Cajal cells. The number of interstitial Cajal cells decreases and their proliferation is affected by the impaired inflammation of the SCF/Kit signal pathway, which further aggravates colitis [44]. These results showed that enhanced expression of c-Kit and SCF mRNA in the colon could alleviate colitis and thus, Shuidouchi could prevent colitis. Simultaneously, the effects of high-concentration Shuidouchi were close to those of sulfasalazine, which is the main drug used to treat colitis.
A large number of inflammatory cells, including neutrophils and lymphocytes, were recruited into the injured tissues during the UC active phase [46]. Immune cells overcame the vascular endothelial cell barrier moving between the body fluids and tissues and involving many steps that are required for cells that flow with the body fluid. Cells are firmly adhered to the blood vessel endothelium, and the cells pass through the intercellular space of the endotheliocyte. Cells then migrate to specific tissues. During this process, cell selectivity and stable adhesion of selected cells are observed. Apart from activating and chemoattracting inflammatory cells, chemokines with increased expression can also trigger other complex inflammatory activities, such as exocytosis, the production of metalloproteinase-degrading matrix, and upregulation of oxidative bursts [47]. Chemokines control the exudation of IL-8 via intracellular signal transduction, which is a typical neutrophil chemokine and activator that mediates inflammatory responses in various ways, including colitis [48]. CINC-1 is a neutrophil chemokine of the IL-8 family, while CXCR2 is a receptor for CINC-1. CXCR2 acts as a mediator to regulate organ-to-organ interactions. Decreasing the expression of CXCR2 in tissues can effectively reduce colonic tissue damage that is caused by colitis [49]. Therefore, the experimental results indicate that Shuidouchi can inhibit colitis by downregulating the expression of CXCR2 and IL-8.
IL-6 is also known as proinflammatory cytokine and it is a widely used cytokine. It can affect inflammation, host defense, and tissue damage through humoral and cellular immune functions. Its production can be regulated by IL-1, interferon, and TNF-α [50]. IL-12 is an inflammatory cytokine that can induce cytotoxic activity of CTL and NK cells and promote their secretion of IFN-gamma, TNF-α, GM-CSF, and other cytokines [51]. TNF-α is the earliest and most important inflammatory mediator during the process of inflammation. It can activate neutrophils and lymphocytes, increase the permeability of vascular endothelial cells, regulate the metabolic activity of other tissues, and promote the synthesis and release of other cytokines [52]. These results showed that Shuidouchi reduced these proinflammatory expression levels and inhibited colitis. In this study, mice were used for all experiments. Because there are several differences between the mouse and human genome, and because the organs are different, the results of this study can confirm the effect of Shuidouchi on colitis only to a certain extent. Therefore, it is necessary to further verify the effect of Shuidouchi on the human body. At the same time, the mechanism of Shuidouchi in the human body also requires comprehensive and in-depth experiments. As basic research, this study has played a specific theoretical role.

5. Conclusions

In this study, through in vitro experiments of Shuidouchi fermented under different conditions, the optimal fermentation conditions were obtained and they are listed in the following: soybeans should be soaked in twice the quantity of water for 12 h, placed it in a glass container, and fermented at 35 °C for 48 h. Under this condition, Shuidouchi fermentation achieved a greater antioxidant effect than that fermented under other conditions, which also contained the highest level of soybean isoflavones. To evaluate the preventive effect of Shuidouchi on colitis, a model of mice with colitis was established by DSS. The experimental results indicate that the Shuidouchi extract could effectively prevent experimental colitis in mice. The preventive effect of Shuidouchi on colitis is directly related to its high soybean isoflavone content, which could be the main mechanism of the intestinal protective effect of Shuidouchi. However, the experimental results remain only applicable for mice, and the mechanism of action in humans remains to be further studied.

Author Contributions

J.Z. and Q.L. performed the majority of the experiments and wrote the manuscript; Y.W., X.L., J.M., and Y.P. contributed to the data analysis; X.Z. designed and supervised the study and read the final manuscript.

Funding

This research was funded by the College Scientific Research Project of Chongqing Chemical Industry Vocational College in 2018 [HZY2018-KJ04] and the Funded Project of Young Backbone Teachers in Chongqing Colleges and Universities, China.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Yang, L.; Yang, H.L.; Tu, Z.C.; Wang, X.L. High-throughput sequencing of microbial community diversity and dynamics during Douchi fermentation. PLoS ONE 2016, 11, e0168166. [Google Scholar] [CrossRef] [PubMed]
  2. Zhao, X.; Song, J.L.; Wang, Q.; Qian, Y.; Li, G.J.; Pang, L. Comparisons of Shuidouchi, Natto, and Cheonggukjang in their physicochemical properties, and antimutagenic and anticancer effects. Food Sci. Biotechnol. 2013, 22, 1077–1084. [Google Scholar] [CrossRef]
  3. Zhao, X.; Li, G.J. Fermentation period and soaked water volume influences on physicochemical properties and in vitro anticancer effect of Shuidouchi. Sci. Technol. Food Ind. 2013, 34, 344–348. [Google Scholar]
  4. Nagata, C.; Takatsuka, N.; Kawakami, N.; Shimizu, H. A prospective cohort study of soy product intake and stomach cancer death. Br. J. Cancer 2002, 87, 31–36. [Google Scholar] [CrossRef] [PubMed]
  5. Pan, H.C.; Yang, D.Y.; Ho, S.P.; Sheu, M.L.; Chen, C.J.; Hwang, S.M.; Chang, M.H.; Cheng, F.C. Escalated regeneration in sciatic nerve crush injury by the combined therapy of human amniotic fluid mesenchymal stem cells and fermented soybean extractions. Natto. J. Biomed. Sci. 2009, 16, 75. [Google Scholar] [CrossRef] [PubMed]
  6. Iwai, K.; Nakaya, N.; Kawasaki, Y.; Matsue, H. Inhibitory effect of natto, a kind of fermented soybeans, on LDL oxidation in vitro. J. Agric. Food Chem. 2002, 50, 3592–3596. [Google Scholar] [CrossRef]
  7. Seo, H.R.; Kim, J.Y.; Kim, J.H.; Park, K.Y. Identification of Bacillus cereus in a chungkukjang that showed high anticancer effects against AGS human gastric adenocarcinoma cells. J. Med. Food 2009, 12, 1274–1280. [Google Scholar] [CrossRef] [PubMed]
  8. Choi, Y.H.; Lim, H.; Heo, M.Y.; Kwon, D.Y.; Kim, H.P. Anti-inflammatory activity of the ethanol extraction of Chungkukjang, Korean fermented bean: 5-lipoxygenase inhibition. J. Med. Food 2008, 11, 539–543. [Google Scholar] [CrossRef]
  9. Zhao, X.; Li, G.J. Influences of soaked water volume on physicochemical properties of Shuidouchi. Sci. Technol. Food Ind. 2013, 34, 217–220. [Google Scholar]
  10. Jia, D.X.; Wu, Y.J.; Li, Y.Z.; Xu, W.Z. Screening and identification of Bacillus for lobster sauce fermentation. Food Sci. 2009, 30, 217–221. [Google Scholar]
  11. Feng, X.; Zhao, X. Study on comparison of physicochemical properties of Natto fermented with different vessels. China Condiment 2016, 41, 77–81. [Google Scholar]
  12. Suo, H.; Feng, X.; Zhu, K.; Wang, C.; Zhao, X.; Kan, J. Shuidouchi (fermented soybean) fermented in different vessels attenuates HCl/ethanol-induced gastric mucosal injury. Molecules 2015, 20, 19748–19763. [Google Scholar] [CrossRef] [PubMed]
  13. Xu, A.Q.; Li, Z.J.; Wang, Y.L.; Liu, P. Progress in the researches on gut-health-oriented functional foods. Food Mach. 2010, 26, 158–163. [Google Scholar]
  14. Zhao, M.J.; Cai, H.Y.; Jiang, Z.L.; Li, Y.; Zhang, H.; Feng, F.Q. High fat diet, gut microbiota and metabolic health. Food Sci. 2018, 39, 336–343. [Google Scholar]
  15. Bibi, S.; Kowalski, R.J.; Zhang, S.; Ganjyal, G.M.; Zhu, M.J. Stability and functionality of grape pomace used as a nutritive additiveduring extrusion process. J. Food Process Technol. 2017, 8, 6. [Google Scholar]
  16. Bibi, S.; Kang, Y.; Du, M.; Zhu, M.J. Maternal high-fat diet consumption enhances offspring susceptibility to DSS-induced colitis in mice. Obesity 2017, 25, 901–908. [Google Scholar] [CrossRef] [PubMed]
  17. Chen, X.; Zhao, X.; Wang, H.; Yang, Z.; Li, J.; Suo, H. Prevent effects of Lactobacillus fermentum HY01 on dextran sulfate sodium-induced colitis in mice. Nutrients 2017, 9, 545. [Google Scholar] [CrossRef]
  18. Qian, Y.; Zhao, X.; Kan, J.Q. Preventive effect of resistant starch on activated carbon-induced constipation in mice. Exp. Ther. Med. 2013, 6, 228–232. [Google Scholar] [CrossRef] [Green Version]
  19. Feng, X.; Zhao, X. Study on preventive effects of different vessels fermented Shuidouchi on CCl4 induced hepatic damage. Sci. Technol. Food Ind. 2016, 37, 338–342. [Google Scholar]
  20. Finkel, T.; Holbrook, N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408, 239–247. [Google Scholar] [CrossRef]
  21. Jasprica, I.; Bojic, M.; Mornar, A.; Besic, E.; Bucan, K.; Medic-Saric, M. Evaluation of antioxidative activity of croatian propolis samples using DPPH· and ABTS·+ stable free radical assays. Molecules 2007, 12, 1006–1021. [Google Scholar] [CrossRef] [PubMed]
  22. Harman, D. Aging: A theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11, 298–300. [Google Scholar] [CrossRef] [PubMed]
  23. Kashyap, M.K.; Yadav, V.; Sherawat, B.S.; Jain, S.; Kumari, S.; Khullar, M.; Sharma, P.C.; Nath, R. Different antioxidants status, total antioxidant power and free radicals in essential hypertension. Mol. Cell Biochem. 2005, 277, 89–99. [Google Scholar] [CrossRef] [PubMed]
  24. Li, H.J.; Zhou, W.; Yu, J.P. Therapeutic effects of antioxidant on inflammatory injury and relevant mechanism in patients with ulcerative colitis. Chin. J. Mod. Med. 2009, 19, 459–461. [Google Scholar]
  25. Lee, C.H.; Yang, L.; Xu, Z.X.; Yeung, S.Y.V.; Huang, Y.; Chen, Z.Y. Relative antioxidant activity of soybean isoflavones and their glycosides. Food Chem. 2005, 90, 735–741. [Google Scholar] [CrossRef]
  26. Jiang, Y.; Lv, Z.S. Relationship between Helicobacter pylori and ulcerative colitis. World Chin. J. Digestol. 2007, 15, 2909–2913. [Google Scholar]
  27. Chen, G.R.; Zhang, Y.; Zheng, Y.Q.; Ren, D.J.; Hei, X.J. Literature analysis of recent 10 years in the treatment of ulcerative colitis using herbal enema. Asia-Pac.Tradi. Med. 2017, 13, 61–63. [Google Scholar]
  28. Strober, W.; Fuss, I.J.; Blumberg, R.S. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 2002, 20, 495–549. [Google Scholar] [CrossRef]
  29. Zhu, Y.P.; Lin, S.M.; Huang, S.; Luo, Z.Q. Clinical effect of No.1 Shuiliao decoction in treatment of diarrhea-predominant irritable bowel syndrome (damp-heat type) and its influence on plasma nitric oxide and endothelin. J. Guangxi Tradi. Chin. Med. Univ. 2007, 10, 10–12. [Google Scholar]
  30. Li, X.; Wang, Q.; Xu, H.; Tao, L.; Lu, J.; Cai, L.; Wang, C. Somatostatin regulates tight junction proteins expression in colitis mice. Int. J. Clin. Exp. Pathol. 2014, 7, 2153–2162. [Google Scholar]
  31. Mantyh, C.R.; Vigna, S.R.; Bollinger, R.R.; Mantyh, P.W.; Maggio, J.E.; Pappas, T.N. Differential expression of substance P receptors in patients with Crohn’s disease and ulcerative colitis. Gastroenterology 1995, 109, 850–860. [Google Scholar] [CrossRef]
  32. Goldin, E.; Karmeli, F.; Selinger, Z.; Rachmilewitz, D. Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation. Dig. Dis. Sci. 1989, 34, 754–757. [Google Scholar] [CrossRef]
  33. Kassim, S.K.; El Touny, M.; El Guinaidy, M.; El Moghni, M.A.; El Mohsen, A.A. Serum nitrates and vasoactive intestinal peptide in patients with gastroesophageal reflux disease. Clin. Biochem. 2002, 35, 641–646. [Google Scholar] [CrossRef]
  34. Matsuoka, K.; Inoue, N.; Sato, T.; Okamoto, S.; Hisamatsu, T.; Kishi, Y.; Sakuraba, A.; Hitotsumatsu, O.; Ogata, H.; Koganei, K.; et al. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn’s disease. Gut 2004, 53, 1303–1308. [Google Scholar] [CrossRef] [PubMed]
  35. Yue, W.J.; Liu, Y.; Xu, W.; Dong, L.; Luo, X.T.; Jiang, W.R.; Sun, X.; Zhong, L.; Liu, J. The expressions of IL-2, IL-4, IL-17 and IL-10 in ulcerative colitis (UC) mucosa and its relation with disease activity. Fudan Univ. J. Med. Sci. 2012, 39, 454–459. [Google Scholar]
  36. Mustafa, A.; El-Medany, A.; Hagar, H.H.; Elmedany, G. Ginkgo biloba attenuates mucosal damage in a rat model of ulcerative colitis. Pharm. Res. 2006, 53, 324–330. [Google Scholar] [CrossRef] [PubMed]
  37. Osman, N.; Adawi, D.; Ahrné, S.; Jeppsson, B.; Molin, G. Probiotics and blueberry attenuate the severity of dextran sulfate sodium (DSS)-induced colitis. Dig. Dis. Sci. 2008, 53, 2464–2473. [Google Scholar] [CrossRef]
  38. Fiocchi, C. Inflammatory bowel disease: New insights into mechanisms of inflammation and increasingly customized approaches to diagnosis and therapy. Curr. Opin. Gastroenterol. 2004, 20, 309–310. [Google Scholar] [CrossRef]
  39. Boettger, M.K.; Uceyler, N.; Zelenka, M.; Schmitt, A.; Reif, A.; Chen, Y.; Sommer, C. Differences in inflammatory pain in nNOS-, iNOS- and eNOS-deficient mice. Eur. J. Pain. 2007, 11, 810–818. [Google Scholar] [CrossRef] [Green Version]
  40. Sasaki, M.; Bharwani, S.; Jordan, P.; Elrod, J.W.; Grisham, M.B.; Jackson, T.H.; Lefer, D.J.; Alexander, J.S. Increased disease activity in eNOS-deficient mice in experimental colitis. Free Radic. Biol. Med. 2003, 35, 1679–1687. [Google Scholar] [CrossRef]
  41. Liu, J.; Wang, A.; Li, L.; Huang, Y.; Xue, P.; Hao, A. Oxidative stress mediates hippocampal neuron death in rats after lithium-pilocarpine-induced status epilepticus. Seizure 2010, 19, 165–172. [Google Scholar] [CrossRef] [PubMed]
  42. Porras, M.; Martín, M.T.; Torres, R.; Vergara, P. Cyclical upregulated iNOS and long-term downregulated nNOS are the bases for relapse and quiescent phases in a rat model of IBD. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290, 423–430. [Google Scholar] [CrossRef] [PubMed]
  43. Youn, J.; Lee, J.S.; Na, H.K.; Kundu, J.K.; Surh, Y.J. Resveratrol and piceatannol inhibit iNOS expression and NF-kappaB activation in dextran sulfate sodium-induced mouse colitis. Nutr. Cancer 2009, 61, 847–854. [Google Scholar] [CrossRef] [PubMed]
  44. Wang, X.Y.; Zarate, N.; Soderholm, J.D.; Bourgeois, J.M.; Liu, L.W.; Huizinga, J.D. Ultrastructural injury to interstitial cells of Cajal and communication with mast cells in Crohn’s disease. Neurogastroenterol. Motil. 2007, 19, 349–364. [Google Scholar] [CrossRef] [PubMed]
  45. Galli, S.J.; Tsai, M.; Wershil, B.K. The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am. J. Pathol. 1993, 142, 965–974. [Google Scholar] [PubMed]
  46. Abron, J.D.; Singh, N.P.; Price, R.L.; Nagarkatti, M.; Nagarkatti, P.S.; Singh, U.P. Genistein induces macrophage polarization and systemic cytokine to ameliorate experimental colitis. PLoS ONE 2018, 13, e0199631. [Google Scholar] [CrossRef] [PubMed]
  47. Damiani, C.R.; Benetton, C.A.; Stoffel, C.; Bardini, K.C.; Cardoso, V.H.; Di Giunta, G.; Pinho, R.A.; Dal-Pizzol, F.; Streck, E.L. Oxidative stress and metabolism in animal model of colitis induced by dextran sulfate sodium. J. Gastroenterol. Hepatol. 2007, 22, 1846–1851. [Google Scholar] [CrossRef]
  48. Izutani, R.; Loh, E.Y.; Reinecker, H.C.; Ohno, Y.; Fusunyan, R.D.; Lichtenstein, G.R.; Rombeau, J.L.; Macdermott, R.P. Increased expression of interleukin-8 mRNA in ulcerative colitis and Crohn’s disease mucosa and epithelial cells. Inflamm. Bowel Dis. 1995, 1, 37–47. [Google Scholar] [CrossRef]
  49. Zhang, T.; Shi, B.; Chen, J.Y.; Pan, F. Expression and significance of cytokine-induced neutrophil chemoattractant-1 and CXC chemokine receptor 2 in a rat model of colitis. World Chin. J. Digestol. 2009, 17, 78–82. [Google Scholar] [CrossRef]
  50. Hozumi, H.; Russell, J.; Vital, S.; Granger, D.N. IL-6 mediates the intestinal microvascular thrombosis associated with experimental colitis. Inflamm. Bowel. Dis. 2016, 22, 560–568. [Google Scholar] [CrossRef]
  51. Ebrahimi Daryani, N.; Sadr, M.; Soltani, S.; Saghazadeh, A.; Moossavi, S.; Shahkarami, S.; Farhadi, E.; Rezaei, N. Association of T helper 1 cytokine gene single nucleotide polymorphisms with ulcerative colitis and Crohn’s disease. Dig. Dis. 2019, 37, 21–32. [Google Scholar] [CrossRef] [PubMed]
  52. Koh, S.J.; Kim, J.M.; Kim, I.K.; Ko, S.H.; Kim, J.S. Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer. J. Gastroenterol. Hepatol. 2014, 29, 502–510. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Technological design of Shuidouchi. (A) Soybeans fermented at different temperatures; (B) Soybeans fermented for different durations; (C) Soybeans fermented in different quantities of soaking water; and, (D) Soybeans fermented in different containers.
Figure 1. Technological design of Shuidouchi. (A) Soybeans fermented at different temperatures; (B) Soybeans fermented for different durations; (C) Soybeans fermented in different quantities of soaking water; and, (D) Soybeans fermented in different containers.
Applsci 09 00005 g001
Figure 2. Standard curve of soybean isoflavone content (genistein).
Figure 2. Standard curve of soybean isoflavone content (genistein).
Applsci 09 00005 g002
Figure 3. Soybean isoflavone contents of Shuidouchi fermented at different temperatures. a–c Mean values with different letters indicate significant differences (p < 0.05). US: unfermented soybean; 30-FSDC (fermented Shuidouchi): 30 °C fermented Shuidouchi; 35-FSDC: 35 °C fermented Shuidouchi; 40-FSDC: 40 °C fermented Shuidouchi.
Figure 3. Soybean isoflavone contents of Shuidouchi fermented at different temperatures. a–c Mean values with different letters indicate significant differences (p < 0.05). US: unfermented soybean; 30-FSDC (fermented Shuidouchi): 30 °C fermented Shuidouchi; 35-FSDC: 35 °C fermented Shuidouchi; 40-FSDC: 40 °C fermented Shuidouchi.
Applsci 09 00005 g003
Figure 4. DPPH (2,2-Diphenyl-1-picrylhydrazyl) (A), ABTS+ (2,2’-azino-bis(3-ethylbenzthiazoline) 6-sulphonic acid) (B), and hydroxyl (C) free radical scavenging capacity of Shuidouchi fermented at different fermentation temperatures. 30-FSDC: 30 °C fermented Shuidouchi; 35-FSDC: 35 °C fermented Shuidouchi; 40-FSDC: 40 °C fermented Shuidouchi.
Figure 4. DPPH (2,2-Diphenyl-1-picrylhydrazyl) (A), ABTS+ (2,2’-azino-bis(3-ethylbenzthiazoline) 6-sulphonic acid) (B), and hydroxyl (C) free radical scavenging capacity of Shuidouchi fermented at different fermentation temperatures. 30-FSDC: 30 °C fermented Shuidouchi; 35-FSDC: 35 °C fermented Shuidouchi; 40-FSDC: 40 °C fermented Shuidouchi.
Applsci 09 00005 g004
Figure 5. Soybean isoflavone contents on Shuidouchi fermented at different times. a–c Mean values with different letters in the bar indicate significant differences (p < 0.05). US: unfermented soybean; 24h-FSDC: 24 h fermented Shuidouchi; 48h-FSDC: 48 h fermented Shuidouchi; 72h-FSDC: 72 h fermented Shuidouchi.
Figure 5. Soybean isoflavone contents on Shuidouchi fermented at different times. a–c Mean values with different letters in the bar indicate significant differences (p < 0.05). US: unfermented soybean; 24h-FSDC: 24 h fermented Shuidouchi; 48h-FSDC: 48 h fermented Shuidouchi; 72h-FSDC: 72 h fermented Shuidouchi.
Applsci 09 00005 g005
Figure 6. DPPH (A), ABTS+ (B), and hydroxyl (C) free radical scavenging capacity of Shuidouchi with different fermentation durations. 24h-FSDC: 24 h fermented Shuidouchi; 48h-FSDC: 48 h fermented Shuidouchi; 72h-FSDC: 72 h fermented Shuidouchi.
Figure 6. DPPH (A), ABTS+ (B), and hydroxyl (C) free radical scavenging capacity of Shuidouchi with different fermentation durations. 24h-FSDC: 24 h fermented Shuidouchi; 48h-FSDC: 48 h fermented Shuidouchi; 72h-FSDC: 72 h fermented Shuidouchi.
Applsci 09 00005 g006
Figure 7. Soybean isoflavone contents of Shuidouchi soaked in different water volumes. a–c Mean values with different letters in the bar are significantly different (p < 0.05). US: unfermented soybean; 1Fold-FSDC: 1-fold soaking water of soybeans for Shuidouchi fermentation; 2Fold-FSDC: 2-fold soaking water of soybeans for Shuidouchi fermentation; 3Fold-FSDC: 3-fold soaking water of soybeans for Shuidouchi fermentation.
Figure 7. Soybean isoflavone contents of Shuidouchi soaked in different water volumes. a–c Mean values with different letters in the bar are significantly different (p < 0.05). US: unfermented soybean; 1Fold-FSDC: 1-fold soaking water of soybeans for Shuidouchi fermentation; 2Fold-FSDC: 2-fold soaking water of soybeans for Shuidouchi fermentation; 3Fold-FSDC: 3-fold soaking water of soybeans for Shuidouchi fermentation.
Applsci 09 00005 g007
Figure 8. DPPH (A), ABTS+ (B), and hydroxyl (C) free radical scavenging capacity of Shuidouchi at different soaking water levels. 1Fold-FSDC: 1-fold soaking water of soybeans for Shuidouchi fermentation; 2Fold-FSDC: 2-fold soaking water of soybeans for Shuidouchi fermentation; 3Fold-FSDC: 3-fold soaking water of soybeans for Shuidouchi fermentation.
Figure 8. DPPH (A), ABTS+ (B), and hydroxyl (C) free radical scavenging capacity of Shuidouchi at different soaking water levels. 1Fold-FSDC: 1-fold soaking water of soybeans for Shuidouchi fermentation; 2Fold-FSDC: 2-fold soaking water of soybeans for Shuidouchi fermentation; 3Fold-FSDC: 3-fold soaking water of soybeans for Shuidouchi fermentation.
Applsci 09 00005 g008
Figure 9. Soybean isoflavone contents of Shuidouchi fermented in different containers. a–c Mean values with different letters in the bar are significantly different (p < 0.05). US: unfermented soybean; C-FSDC: Ceramic container used for Shuidouchi fermentation; G-FSDC: Glass container used for Shuidouchi fermentation; M-FSDC: Metal container used for Shuidouchi fermentation.
Figure 9. Soybean isoflavone contents of Shuidouchi fermented in different containers. a–c Mean values with different letters in the bar are significantly different (p < 0.05). US: unfermented soybean; C-FSDC: Ceramic container used for Shuidouchi fermentation; G-FSDC: Glass container used for Shuidouchi fermentation; M-FSDC: Metal container used for Shuidouchi fermentation.
Applsci 09 00005 g009
Figure 10. DPPH (A), ABTS+ (B), and hydroxyl (C) free radical scavenging capacity of Shuidouchi fermented in different containers. C-FSDC: Ceramic container used for Shuidouchi fermentation; G-FSDC: Glass container used for Shuidouchi fermentation; M-FSDC: Metal container used for Shuidouchi fermentation.
Figure 10. DPPH (A), ABTS+ (B), and hydroxyl (C) free radical scavenging capacity of Shuidouchi fermented in different containers. C-FSDC: Ceramic container used for Shuidouchi fermentation; G-FSDC: Glass container used for Shuidouchi fermentation; M-FSDC: Metal container used for Shuidouchi fermentation.
Applsci 09 00005 g010
Figure 11. Disease activity index of mice with colitis. a–e Mean values with different letters in the same day indicate significant difference (p < 0.05). SDC-L: 2 g/kg Shuidouchi extract treatment; SDC-H: 4 g/kg Shuidouchi extract treatment; Sulfasalazine: 20 mg/kg sulfasalazine treatment.
Figure 11. Disease activity index of mice with colitis. a–e Mean values with different letters in the same day indicate significant difference (p < 0.05). SDC-L: 2 g/kg Shuidouchi extract treatment; SDC-H: 4 g/kg Shuidouchi extract treatment; Sulfasalazine: 20 mg/kg sulfasalazine treatment.
Applsci 09 00005 g011
Figure 12. mRNA expression levels of neuronal nitric oxide synthase (nNOS), endothelial nitric oxide synthase (eNOS), and inducible nitric oxide synthase (iNOS) in the colon tissue of mice. Values represent the mean ± standard deviation. a–e Mean values with different letters in the same bars indicate significant difference (p < 0.05). SDC-L: 2 g/kg Shuidouchi extract treatment; SDC-H: 4 g/kg Shuidouchi extract treatment; Sulfasalazine: 20 mg/kg sulfasalazine treatment.
Figure 12. mRNA expression levels of neuronal nitric oxide synthase (nNOS), endothelial nitric oxide synthase (eNOS), and inducible nitric oxide synthase (iNOS) in the colon tissue of mice. Values represent the mean ± standard deviation. a–e Mean values with different letters in the same bars indicate significant difference (p < 0.05). SDC-L: 2 g/kg Shuidouchi extract treatment; SDC-H: 4 g/kg Shuidouchi extract treatment; Sulfasalazine: 20 mg/kg sulfasalazine treatment.
Applsci 09 00005 g012
Figure 13. mRNA expression levels of c-Kit and SCF in colon tissues of mice. Values represent the mean ± standard deviation. a–e Mean values with different letters in the same bars indicate significant difference (p < 0.05). SDC-L: 2 g/kg Shuidouchi extract treatment; SDC-H: 4 g/kg Shuidouchi extract treatment; Sulfasalazine: 20 mg/kg sulfasalazine treatment.
Figure 13. mRNA expression levels of c-Kit and SCF in colon tissues of mice. Values represent the mean ± standard deviation. a–e Mean values with different letters in the same bars indicate significant difference (p < 0.05). SDC-L: 2 g/kg Shuidouchi extract treatment; SDC-H: 4 g/kg Shuidouchi extract treatment; Sulfasalazine: 20 mg/kg sulfasalazine treatment.
Applsci 09 00005 g013
Figure 14. mRNA expression levels of interleukin-8 (IL-8) and C-X-C chemokine receptor type 2 (CXCR2) in the colon tissue of mice. Values represent the mean ± standard deviation. a–e Mean values with different letters in the same bars indicate significant difference (p < 0.05). SDC-L: 2 g/kg Shuidouchi extract treatment; SDC-H: 4 g/kg Shuidouchi extract treatment; Sulfasalazine: 20 mg/kg sulfasalazine treatment.
Figure 14. mRNA expression levels of interleukin-8 (IL-8) and C-X-C chemokine receptor type 2 (CXCR2) in the colon tissue of mice. Values represent the mean ± standard deviation. a–e Mean values with different letters in the same bars indicate significant difference (p < 0.05). SDC-L: 2 g/kg Shuidouchi extract treatment; SDC-H: 4 g/kg Shuidouchi extract treatment; Sulfasalazine: 20 mg/kg sulfasalazine treatment.
Applsci 09 00005 g014
Figure 15. Protein expression levels of IL-6, IL-12, and tumor necrosis factor-α (TNF-α) in the colon tissue of mice. SDC-L: 2 g/kg Shuidouchi extract treatment; SDC-H: 4 g/kg Shuidouchi extract treatment; sulfasalazine: 20 mg/kg sulfasalazine treatment.
Figure 15. Protein expression levels of IL-6, IL-12, and tumor necrosis factor-α (TNF-α) in the colon tissue of mice. SDC-L: 2 g/kg Shuidouchi extract treatment; SDC-H: 4 g/kg Shuidouchi extract treatment; sulfasalazine: 20 mg/kg sulfasalazine treatment.
Applsci 09 00005 g015
Table 1. DPPH (2,2-Diphenyl-1-picrylhydrazyl) determination method.
Table 1. DPPH (2,2-Diphenyl-1-picrylhydrazyl) determination method.
No.Sample reaction System
A13.9 mL DPPH solution +100 µL sample solution
A23.9 mL anhydrous ethanol +100 µL sample solution
A33.9 mL DPPH solution +100 µL 80% methanol solution
Table 2. ABTS+ (2,2’-azino-bis(3-ethylbenzthiazoline) 6-sulphonic acid) determination.
Table 2. ABTS+ (2,2’-azino-bis(3-ethylbenzthiazoline) 6-sulphonic acid) determination.
No.Sample Reaction System
A15 mL ABTS reaction solution +200 µL sample solution
A25 mL anhydrous ethanol +200 µL sample solution
A35 mL ABTS solution +200 µL 80% methanol solution
Table 3. Hydroxyl radical determination.
Table 3. Hydroxyl radical determination.
No.Sample Reaction System
A1300 µL 80% methanol solution +2.0 mL FeSO4 +1.0 mL salicylic acid ethanol solution +1.0 mL H2O2
A2300 µL sample solution +2.0 mL FeSO4 +1.0 mL salicylic acid ethanol solution +1.0 mL H2O2
A3300 µL sample solution +2.0 mL FeSO4 +1.0 mL salicylic acid ethanol solution +1.0 mL 80% methanol solution
Table 4. Disease activity index (DAI) scoring standard.
Table 4. Disease activity index (DAI) scoring standard.
Weight Loss (%)Shape of StoolOccult Blood/Bloody StoolScore
0NormalNegative0
1–5Soft stoolNegative1
6–10Soft stoolOccult blood2
11–15DiarrheaOccult blood3
>15DiarrheaBlood stool4
Table 5. Sequences of primers used.
Table 5. Sequences of primers used.
Gene NameSequences
nNOSForward: 5′-GAG AGG ATT CTG AAG ATG AGG-3′
Reverse: 5′-TTG CTA ATG AGG GAG TTG TTC-3′
eNOSForward: 5′-TGT TTG TCT GCG GCG ATG T-3′
Reverse: 5′-GGG TGC GTA TGC GGC TTG TC-3′
iNOSForward: 5′-CAT TGG AAG TGA AGC GTT TCG-3′
Reverse: 5′-CAC AGA ACT GAG GGT ACA-3′
c-KitForward: 5′-CATAGCCCAGGTAAAGCACAAT-3′
Reverse: 5′-GAACACTCCAGAATCGTCAACTC-3′
SCFForward: 5′-TCAGGGACTACGCTGCGAAAG-3′
Reverse: 5′-AAGAGCTGGCAGACCGACTCA-3′
IL-8Forward: 5′-CTAGGCATCTTCGTCCGTCC-3′
Reverse: 5′-TTGGGCCAACAGTAGCCTTC-3′
CXCR2Forward: 5′-TCTGCTCACAAACAGCGTCGTA-3′
Reverse: 5′-GAGTGGCATGGGACAGCATC-3′
GAPDHForward: 5′-TGC ACC ACC AAC TGC TTA G-3′
Reverse: 5′-GAT GCA GGG ATG ATG TTC-3′
nNOS: neuronal nitric oxide synthase; eNOS: endothelial nitric oxide synthase; iNOS: inducible nitric oxide synthase; SCF: stem cell factor; IL-8: interleukin 8; CXCR2: C-X-C chemokine receptor type 2; GAPDH: glyceraldehyde-3-phosphate dehydrogenase.
Table 6. DPPH (A), ABTS+ (B), and hydroxyl (C) free radical scavenging capacity of Shuidouchi at different fermentation temperatures.
Table 6. DPPH (A), ABTS+ (B), and hydroxyl (C) free radical scavenging capacity of Shuidouchi at different fermentation temperatures.
TypeGroupLinear regression EquationIC50 (mg/mL)
DPPH free radical scavenging capacity30-FSDCY = 27.514X − 9.4667   R2 = 0.9782.06 ± 0.03 a
35-FSDCY = 31.937X − 4.64   R2 = 0.97191.71 ± 0.03 c
40-FSDCY = 30.931X − 8.2133   R2 = 0.96241.88 ± 0.02 b
ABTS+ free radical scavenging capacity30-FSDCY = 11.857X − 2.8667   R2 = 0.9974.46 ± 0.02 a
35-FSDCY = 20.24X − 4.12   R2 = 0.97672.67 ± 0.03 c
40-FSDCY = 16.686X-4.4333   R2 = 0.98013.26 ± 0.02 b
Hydroxyl free radical scavenging capacity30-FSDCY = 8.96X − 2.1133   R2 = 0.99535.82 ± 0.03 a
35-FSDCY = 13.417X − 0.28   R2 = 0.98693.75 ± 0.02 c
40-FSDCY = 11.806X − 2.26   R2 = 0.99834.43 ± 0.03 b
Values represent the the mean ± standard deviation. a–c Mean values with different letters in the same row are significantly different (p < 0.05). 30-FSDC: 30 °C fermented Shuidouchi; 35-FSDC: 35 °C fermented Shuidouchi; 40-FSDC: 40 °C fermented Shuidouchi.
Table 7. DPPH (A), ABTS+ (B), and hydroxyl (C) free radical scavenging capacities of Shuidouchi extract fermented for different durations.
Table 7. DPPH (A), ABTS+ (B), and hydroxyl (C) free radical scavenging capacities of Shuidouchi extract fermented for different durations.
TypeGroupLinear Regression EquationIC50 (mg/mL)
DPPH free radical scavenging capacity24h-FSDCY = 22.486X − 9.3333   R2 = 0.99962.64 ± 0.01 a
48h-FSDCY = 31.937X − 4.64   R2 = 0.97191.71 ± 0.03 c
72h-FSDCY = 30.749X − 7.9267   R2 = 0.98891.88 ± 0.03 b
ABTS+ free radical scavenging capacity24h-FSDCY = 11.143X − 4.9   R2 = 0.98844.93 ± 0.02 a
48h-FSDCY = 20.24X − 4.12   R2 = 0.97672.67 ± 0.03 c
72h-FSDCY = 15.76X − 4.9467   R2 = 0.96633.49 ± 0.02 b
Hydroxyl free radical scavenging capacity24h-FSDCY = 7.6114X − 1.4533   R2 = 0.99696.76 ± 0.02 a
48h-FSDCY = 13.417X − 0.28   R2 = 0.98693.75 ± 0.03 c
72h-FSDCY = 10.269X − 1.3867   R2 = 0.99675.00 ± 0.02 b
Values presented are the mean ± standard deviation. a–c Mean values with different letters in the same row are significantly different (p < 0.05). 24h-FSDC: 24 h fermented Shuidouchi; 48h-FSDC: 48 h fermented Shuidouchi; 72h-FSDC: 72 h fermented Shuidouchi.
Table 8. DPPH (A), ABTS+ (B), and hydroxyl (C) free radical scavenging capacity of Shuidouchi soaked in different amounts of water.
Table 8. DPPH (A), ABTS+ (B), and hydroxyl (C) free radical scavenging capacity of Shuidouchi soaked in different amounts of water.
TypeGroupLinear Regression EquationIC50 (mg/mL)
DPPH free radical scavenging capacity1Fold-FSDCY = 25.32X − 98.66   R2 = 0.98072.32 ± 0.02 a
2Fold-FSDCY = 31.937X − 94.64   R2 = 0.97191.71 ± 0.02 c
3Fold-FSDCY = 30.909X − 95.2733   R2 = 0.98161.79 ± 0.02 b
ABTS+ free radical scavenging capacity1Fold-FSDCY = 9.2571X − 91.3   R2 = 0.9985.54 ± 0.01 a
2Fold-FSDCY = 20.24X − 94.12   R2 = 0.97672.67 ± 0.02 c
3Fold-FSDCY = 18.589X − 93.98   R2 = 0.97042.90 ± 0.03 b
Hydroxyl free radical scavenging capacity1Fold-FSDCY = 9.2971X − 91.32   R2 = 0.97325.52 ± 0.03 a
2Fold-FSDCY = 13.417X − 90.28   R2 = 0.98693.75 ± 0.02 c
3Fold-FSDCY = 11.983X + 0.68   R2 = 0.99394.23 ± 0.03 b
Values present the mean ± standard deviation. a–c Mean values with different letters in the same row are significantly different (p < 0.05). 1Fold-FSDC: 1-fold soaking water for Shuidouchi fermentation; 2Fold-FSDC: 2-fold soaking water for Shuidouchi fermentation; 3Fold-FSDC: 3-fold soaking water for Shuidouchi fermentation.
Table 9. DPPH (A), ABTS+ (B), and hydroxyl (C) free radical scavenging capacity of Shuidouchi fermentated in different containers.
Table 9. DPPH (A), ABTS+ (B), and hydroxyl (C) free radical scavenging capacity of Shuidouchi fermentated in different containers.
TypeGroupLinear Regression EquationIC50 (mg/mL)
DPPH free radical scavenging capacityC-FSDCY = 30.697X − 6.72   R2 = 0.96041.85 ± 0.02 a
G-FSDCY = 31.937X − 4.64   R2 = 0.97191.71 ± 0.03 c
M-FSDCY = 29.074X − 7.3133   R2 = 0.95971.97 ± 0.02 b
ABTS+ free radical scavenging capacityC-FSDCY = 16.937X − 3.8733   R2 = 0.98063.18 ± 0.02 a
G-FSDCY = 20.24X − 4.12   R2 = 0.97672.67 ± 0.02 c
M-FSDCY = 15.371X − 4.0667   R2 = 0.97763.52 ± 0.03 b
Hydroxyl free radical scavenging capacityC-FSDCY = 12.246X − 1.6467   R2 = 0.99764.22 ± 0.02 a
G-FSDCY = 13.417X − 0.28   R2 = 0.98693.75 ± 0.02 c
M-FSDCY = 11.383X − 3.0533   R2 = 0.99484.66 ± 0.02 b
Values represent the mean ± standard deviation. a–c Mean values with different letters in the same row are significantly different (p < 0.05). C-FSDC: Ceramic container used for Shuidouchi fermentation; G-FSDC: Glass container used for Shuidouchi fermentation; M-FSDC: Metal container used for Shuidouchi fermentation.
Table 10. Colon lengths and colon weight-to-colon length ratios.
Table 10. Colon lengths and colon weight-to-colon length ratios.
Group.Colon Lengths (cm)Colon Weight-to-Colon Length Ratios (mg/cm)
Normal9.3 ± 0.3 a22.1 ± 1.8 a
Control4.1 ± 0.4 e43.8 ± 2.2 e
SDC-L5.6 ± 0.4 d38.6 ± 1.6 d
SDC-H7.1 ± 0.3 c34.2 ± 1.2 c
Sulfasalazine7.8 ± 0.3 b29.7 ± 1.4 b
Values represent the mean ± standard deviation. a–e Mean values with different letters in the same row indicate significant difference (p < 0.05). SDC-L: 2 g/kg Shuidouchi extract treatment; SDC-H: 4 g/kg Shuidouchi extract treatment; Sulfasalazine: 20 mg/kg sulfasalazine treatment.
Table 11. Endothelin (ET), somatostatin (SS), substance P (SP), and vasoactive intestinal peptide (VIP) serum levels in mice.
Table 11. Endothelin (ET), somatostatin (SS), substance P (SP), and vasoactive intestinal peptide (VIP) serum levels in mice.
Group.ET (pg/mL)SS (pg/mL)SP (pg/mL)VIP (pg/mL)
Normal6.12 ± 0.16 e59.87 ± 2.97 a38.14 ± 1.56 e66.61 ± 2.42 a
Control23.08 ± 0.39 a23.54 ± 2.02 e63.41 ± 2.18 a29.36 ± 2.11 e
SDC-L17.76 ± 0.31 b31.02 ± 2.12 d53.10 ± 2.06 b38.71 ± 1.69 d
SDC-H11.62 ± 0.25 c42.58 ± 2.51 c46.02 ± 1.62 c46.31 ± 2.11 c
Sulfasalazine9.47 ± 0.19 d49.71 ± 2.37 b42.31 ± 1.55 d52.36 ± 2.01 b
Values represent the mean ± standard deviation. a–e Mean values with different letters in the same row indicate significant difference (p < 0.05). SDC-L: 2 g/kg Shuidouchi extract treatment; SDC-H: 4 g/kg Shuidouchi extract treatment; sulfasalazine: 20 mg/kg sulfasalazine treatment. ET: endothelin; SS: somatostatin; SP: substance P; VIP: vasoactive intestinal peptide.
Table 12. Serum cytokine levels of interleukin-2 (IL-2) and interleukin-10 (IL-10) in mice.
Table 12. Serum cytokine levels of interleukin-2 (IL-2) and interleukin-10 (IL-10) in mice.
GroupIL-2 (pg/mL)IL-10 (pg/mL)
Normal248.20 ± 32.39 a133.56 ± 15.51 e
Control70.82 ± 12.36 d763.52 ± 25.39 a
SDC-L95.63 ± 17.82 c541.02 ± 22.58 b
SDC-H155.88 ± 20.84 bc352.36 ± 20.02 c
Sulfasalazine192.76 ± 22.33 b234.19 ± 24.48 d
Values represent the mean ± standard deviation. a–e Mean values with different letters in the same row indicate significant difference (p < 0.05). SDC-L: 2 g/kg Shuidouchi extract treatment; SDC-H: 4 g/kg Shuidouchi extract treatment; Sulfasalazine: 20 mg/kg sulfasalazine treatment. IL-2: interleukin-2; IL-10: interleukin-10.
Table 13. Myeloperoxidase (MPO), superoxide dismutase (SOD), glutathione (GSH), and malondialdehyde (MDA) levels in colon tissues of mice.
Table 13. Myeloperoxidase (MPO), superoxide dismutase (SOD), glutathione (GSH), and malondialdehyde (MDA) levels in colon tissues of mice.
GroupMPO (mU/mg)GSH (µmol/mg)MDA (nmol/mg) SOD (U/mg)
Normal6.35 ± 0.25 e8.33 ± 0.35 a0.30 ± 0.06 d93.74 ± 4.21 a
Control33.87 ± 2.68 a3.10 ± 0.22 e1.77 ± 0.23 a28.30 ± 3.03 e
SDC-L25.31 ± 1.77 b4.52 ± 0.25 d1.18 ± 0.12 b44.25 ± 2.62 d
SDC-H12.30 ± 1.52 c5.89 ± 0.21 c0.78 ± 0.14 c67.12 ± 2.88 c
Sulfasalazine9.01 ± 1.28 d6.38 ± 0.20 b0.55 ± 0.15 c80.35 ± 2.39 b
Values represent the mean ± standard deviation. a–e Mean values with different letters in the same row indicate significant difference (p < 0.05). SDC-L: 2 g/kg Shuidouchi extract treatment; SDC-H: 4 g/kg Shuidouchi extract treatment; Sulfasalazine: 20 mg/kg sulfasalazine treatment. MPO: myeloperoxidase; GSH: glutathione; MDA: malondialdehyde; SOD: superoxide dismutase.

Share and Cite

MDPI and ACS Style

Zhang, J.; Li, Q.; Wei, Y.; Long, X.; Mu, J.; Pan, Y.; Zhao, X. Process Design of the Antioxidant Shuidouchi and Its Effect on Preventing Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice via Antioxidant Activity. Appl. Sci. 2019, 9, 5. https://doi.org/10.3390/app9010005

AMA Style

Zhang J, Li Q, Wei Y, Long X, Mu J, Pan Y, Zhao X. Process Design of the Antioxidant Shuidouchi and Its Effect on Preventing Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice via Antioxidant Activity. Applied Sciences. 2019; 9(1):5. https://doi.org/10.3390/app9010005

Chicago/Turabian Style

Zhang, Jing, Qin Li, Yang Wei, Xingyao Long, Jianfei Mu, Yanni Pan, and Xin Zhao. 2019. "Process Design of the Antioxidant Shuidouchi and Its Effect on Preventing Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice via Antioxidant Activity" Applied Sciences 9, no. 1: 5. https://doi.org/10.3390/app9010005

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop